The Skinny Premium Is a Lie. It Was Always a Fat Tax.

You’ve noticed it, even if you never said it out loud. The person who loses weight gets a promotion. The person who gains weight stops getting invited to the right meetings. And nobody — nobody — ever puts it in the performance review.

We’ve all been told that weight loss improves career outcomes because healthier people are more productive. That’s the story. That’s the comfortable story. But a new NBER study on GLP-1 weight loss drugs just accidentally pulled the mask off something far uglier: the wage boost from being thin was never about productivity. It was a tax on people society decided were morally defective.

Here’s the setup. GLP-1 drugs like Ozempic and Wegovy have made dramatic weight loss medically attainable in a way it never was before. So researchers asked a deceptively simple question: if weight loss becomes easy and everyone knows it, does the labor market still reward thinness the same way?

The answer is no. And the reason why should make you uncomfortable.

Think about what used to happen. For decades, obesity was framed as a personal failing — a character flaw, a sign of laziness, a lack of discipline. If you were overweight, the implicit logic went, it was your fault. And if you managed to get thin, you had demonstrated something heroic: willpower, grit, self-mastery. Employers rewarded that narrative with better wages, faster promotions, more respect.

The skinny premium wasn’t rewarding thinness. It was rewarding the performance of moral redemption.

Now enter GLP-1s. A weekly injection. Not willpower. Not discipline. Not a redemption arc. Biology. When the cause of obesity shifts from ‘personal failure’ to ‘medical condition treated with a prescription,’ the social judgment that powered the wage gap starts to collapse. And here’s the twist nobody expected: as weight loss becomes democratized, the economic advantage of being thin may actually shrink.

Let that sink in. The same person, the same body, the same skills — valued differently depending on whether society thinks they earned their weight loss through suffering or achieved it through medicine.

This is the paradox at the heart of the study. The more attainable thinness becomes, the less it confers economic advantage — because the stigma that made it valuable in the first place was never about the weight. It was about the blame.

We didn’t pay thin people more because they were more productive. We paid fat people less because we judged them.

If you’ve ever been passed over while heavier, if you’ve ever noticed the shift in how people treat you after weight loss — the sudden warmth, the opened doors, the ‘you look amazing’ comments that feel more like relief than celebration — you already know this. You felt it before you understood it.

And if you work in HR, in hiring, in policy — you need to understand what this means. The GLP-1 boom won’t simply level the playing field. It could reshape it in ways we’re not prepared for. If weight loss is medical, not moral, then every wage gap that was ever justified by ‘they just don’t take care of themselves’ was discrimination wearing a productivity costume.

But here’s where it gets darker. The study implies a bifurcation. Those who can afford GLP-1s — the expensive, branded, insurance-dependent drugs — will still get the thin body. They’ll just stop getting the moral credit for it. Meanwhile, those who can’t access the drugs remain trapped in the old stigma, now amplified: everyone knows there’s a treatment, so why haven’t you taken it?

The stigma doesn’t disappear when treatment arrives. It mutates. It goes from ‘you’re lazy’ to ‘you’re noncompliant.’ Same judgment, new vocabulary.

This is what the study is really about. Not GLP-1s. Not weight loss. It’s about the architecture of social value — how we decide who deserves what, and how fragile those justifications turn out to be when you change one variable.

The skinny premium was never a premium. It was a penalty applied to everyone who didn’t fit the mold, dressed up as a reward for those who did. And now that the mold is cracking, we get to see what was underneath all along: not a meritocracy of discipline, but a hierarchy of judgment.

The most dangerous inequalities are the ones we’ve convinced ourselves are earned.

So the next time someone tells you weight loss improves career outcomes, ask them: improves them compared to what? Compared to being judged as morally defective? That’s not a benefit. That’s the removal of a punishment.

And the fact that we ever called it a ‘premium’ tells you everything you need to know about who was really paying the price.